| Title |
Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis
|
|---|---|
| Published in |
BMC Cancer, June 2014
|
| DOI | 10.1186/1471-2407-14-471 |
| Pubmed ID | |
| Authors |
Gillian K Gresham, George A Wells, Sharlene Gill, Christopher Cameron, Derek J Jonker |
| Abstract |
Advanced pancreatic cancer confers poor prognosis and treatment advancement has been slow. Recent randomized clinical trials (RCTs) have demonstrated survival benefits for combination therapy compared to gemcitabine alone. However, the comparative benefits and harms of available combination chemotherapy treatments are not clear. We therefore conducted a systematic review and Bayesian network meta-analysis to assess the comparative safety and efficacy of chemotherapy regimens for the treatment of advanced pancreatic cancer. |
Mendeley readers
The data shown below were compiled from readership statistics for 120 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 2 | 2% |
| Ecuador | 1 | <1% |
| Unknown | 117 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 23 | 19% |
| Student > Ph. D. Student | 19 | 16% |
| Other | 15 | 13% |
| Student > Bachelor | 15 | 13% |
| Student > Doctoral Student | 12 | 10% |
| Other | 16 | 13% |
| Unknown | 20 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 48 | 40% |
| Agricultural and Biological Sciences | 17 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 5% |
| Biochemistry, Genetics and Molecular Biology | 6 | 5% |
| Arts and Humanities | 4 | 3% |
| Other | 13 | 11% |
| Unknown | 26 | 22% |